SELP (Crizanlizumab Biosimilar) antibody (Biotin)

Catalog No. ABIN7607918

The Humanized Monoclonal anti-SELP (Crizanlizumab Biosimilar) antibody has been validated for FACS. It is suitable to detect SELP (Crizanlizumab Biosimilar) in samples from Human.

Quick Overview for SELP (Crizanlizumab Biosimilar) antibody (Biotin) (ABIN7607918)

Target: SELP (Crizanlizumab Biosimilar)

Reactivity: Human

Host: Humanized

Clonality: Monoclonal

Conjugate: This SELP (Crizanlizumab Biosimilar) antibody is conjugated to Biotin

Application: Flow Cytometry (FACS)

Product Details anti-SELP (Crizanlizumab Biosimilar) Antibody (Biotin)

Purpose: Biotinylated Anti-SELP(crizanlizumab biosimilar) mAb

Isotype: IgG2

Application Details

Application Notes: Flow Cyt 1:100

Restrictions: For Research Use only

Handling

Format: Lyophilized

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Storage: -20 °C,-80 °C

Storage Comment: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Target Details for SELP (Crizanlizumab Biosimilar)

Target: SELP (Crizanlizumab Biosimilar)

Alternative Name: crizanlizumab Biosimilar

Target Type: Biosimilar

Background: Synonyms Target:P-Selectin,CD62P,SELP,GMP-140
Synonyms Antibody:SEG101, SelG1, crizanlizumab-tmca